발가락 굽음증(망치 발가락) 시장 규모는 2024년 126억 9,000만 달러로 평가되었습니다. 2031년에는 29억 8,800만 달러에 달할 것으로 예상되며, 2024-2031년간 11.30%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 전망됩니다.
세계의 발가락 굽음증(망치 발가락) 시장 성장 촉진요인
발가락 굽음증(망치 발가락) 시장 시장 성장 촉진요인은 다양한 요인에 의해 영향을 받을 수 있습니다.
이환율 증가:
인구 고령화, 좌식 생활습관, 부적절한 신발 선택이 발가락 굽음증(망치 발가락) 발병률 증가의 주요 원인으로 작용하고 있습니다.
기술 개발 :
정교한 정형외과 장비의 발달과 최소침습 수술법의 발전으로 치료법의 폭이 넓어지면서 시장 확대에 박차를 가하고 있습니다.
인식 및 진단 향상:
발에 대한 지식 증가와 함께 더 나은 진단 도구가 발가락 굽음증(망치 발가락)을 조기에 발견하고 관리할 수 있게 되면서 수요 증가의 원동력이 되고 있습니다.
비침습적 치료에 대한 선호도:
부목, 보조기 등 저침습적 치료와 비침습적 치료에 대한 환자들의 선호도가 높아지면서 시장을 주도하고 있습니다.
의료비 지출 증가 :
세계적인 의료비 증가와 의료 시설 증가로 인해 발가락 굽음증(망치 발가락) 환자들이 대체 치료를 받기 쉬워지고 있으며, 이는 시장 확대의 원동력이 되고 있습니다.
세계의 발가락 굽음증(망치 발가락) 시장 성장 억제요인
발가락 굽음증(망치 발가락) 시장에는 몇 가지 장애요인과 과제가 있습니다.
비싼 치료비 :
환자에 따라서는 수술, 보조기, 경과 관찰 등 발가락 굽음증(망치 발가락) 치료에 드는 비용이 부담스러울 수 있어 시장 확대에 제약이 될 수 있습니다.
지급 규정 제한:
보험 적용이 불충분하거나 발가락 굽음증(망치 발가락) 치료 시술 및 장비에 대한 지불이 제한적일 경우, 환자들은 필요한 치료를 받으려 하지 않을 수 있으며, 이는 시장 확대에 걸림돌이 될 수 있습니다.
결과와 위험
치료 방법이 개선됐지만, 발가락 굽음증(망치 발가락) 치료에는 고유한 위험과 잠재적 영향이 있습니다. 신경 손상, 감염, 재발 등이 그것입니다. 이는 환자들의 치료 의욕을 떨어뜨려 시장 성장을 저해할 수 있습니다.
대체 요법의 선택:
환자에 따라 물리치료, 침술, 가정요법 등 대체요법이 기존의 발가락 굽음증(망치 발가락) 치료보다 더 효과적일 수 있습니다. 이는 의료 개입의 필요성을 감소시켜 시장 성장에 영향을 미칠 수 있습니다.
개발도상국에서의 지식 부족 :
특히 개발도상국에서는 발가락 굽음증(망치 발가락)의 문제와 치료법에 대한 지식이 부족하여 환자들이 신속한 의료 지원을 받지 못하거나 전통적인 치료법에 의존할 가능성이 있습니다. 이는 시장 성장을 저해할 수 있습니다.
Hammertoe Market size was valued at USD 12.69 Billion in 2024 and is projected to reach USD 29.88 Billion by 2031 , growing at a CAGR of 11.30% during the forecast period 2024-2031.
Global Hammertoe Market Drivers
The market drivers for the Hammertoe Market can be influenced by various factors. These may include:
Growing Incidence Rates:
The aging population, sedentary lifestyles, and inappropriate footwear choices are major contributors to the rising incidence of hammertoe diseases.
Technological developments:
The creation of sophisticated orthopaedic equipment and advances in minimally invasive surgical methods are broadening the range of available treatments, which is propelling market expansion.
Increasing Awareness and Diagnosis:
Better diagnostic tools along with increased knowledge of foot abnormalities are enabling early identification and management of hammertoe, which is driving greater demand.
Preference for Non-Invasive Treatments:
The market is driven by patients' increasing preference for minimally invasive or non-invasive treatment choices, such as splints and orthotic devices.
Growing Healthcare Expenditure:
The global increase in healthcare spending, together with the development of healthcare facilities, is making it easier for people with hammertoes to receive treatment alternatives, which is driving the market's expansion.
Global Hammertoe Market Restraints
Several factors can act as restraints or challenges for the Hammertoe Market. These may include:
Exorbitant therapy Costs:
Some patients may find the costs of hammertoe therapy, which include surgery, orthotic devices, and follow-up care, to be unaffordable, which could restrict market expansion.
Restricted payment rules:
Patients may be discouraged from seeking essential care, which could impede market expansion, if there is insufficient insurance coverage or restricted payment rules for hammertoe treatment procedures and devices.
consequences and Risks
: Although treatment methods have improved, hammertoe procedures still have certain inherent risks and potential consequences. These include nerve injury, infection, and recurrence. As a result, patients may be discouraged from undertaking treatment, which could hinder market growth.
Alternative Therapy Options:
For certain patients, alternative therapies including physical therapy, acupuncture, and home remedies may be more effective than traditional hammertoe treatments. This could lower the need for medical interventions and have an impact on the growth of the market.
Lack of Knowledge in Developing Areas:
Patients may choose to forego prompt medical assistance or turn to traditional remedies due to a lack of knowledge regarding hammertoe problems and treatment alternatives, especially in developing areas. This can impede market growth.
Global Hammertoe Market is Segmented based on the Type, Diagnosis, Treatment, End User, And Geography.
By Type
Flexible hammertoe
Rigid hammertoe
Based on the type, the market is bifurcated into Flexible hammertoe and Rigid hammertoe. The flexible hammertoe is when the toe can still be moved while rigid hammertoe is a condition when the toe becomes rigid & they press the joint out of alignment.
By Diagnosis
Physical exam
X-rays
Others
Based on the diagnosis, the market is bifurcated into a Physical exam, X-rays, and Others. The growing number of hammertoe correction surgeries is predicted to bolster the market in the coming years.
By Treatment
Drugs
Orthotic Devices
Surgery
Others
Based on treatment, the market is bifurcated into Drugs, Orthotic Devices, Surgery, and Others. The surgery sector is anticipated to have the biggest market share. The variables are attributable to the rise in hammertoe procedures.
By End-User
Hospitals
Clinics
Physiotherapy & Orthopedic Centers
Based on the end-user, the market is bifurcated into Hospitals, Clinics, and Physiotherapy & Orthopedic Centers. The hospital segment is anticipated to have the highest CAGR in the forecasted period. The factors can be attributed to the increasing number of patients with capsular tears & fractures and the rise in the number of orthopedic surgeries.
By Geography
North America
Europe
Asia Pacific
Rest of the world
Based on the geographical analysis, the market is bifurcated into North America, Europe, Asia Pacific, and Rest of the world. The largest share in the market will be dominated by North America owing to the rising number of orthopedic specialty care centers & trauma care centers and the growth in the number of players manufacturing hammertoe correction products in this region.
The major players in the Hammertoe Market are:
Stryker
Ex Extremity Medical LLC
Smith & Nephew plc
Zimmer Biomet (formerly Biomet)
Arthrex
Wright Medical Group N.V.
Acumed
OsteoMed
Nextremity Solutions, Inc.
Instratek
Extremity Medical LLC
Arrowhead Medical Device Technologies
Nextremity Solutions
Biometmith & Nephew plc.
Biomet, Inc.
Acumed.